Analyst firms · Morgan Stanley · IQV

Morgan Stanley IQV price target and rating history

IQVIA Holdings Inc. (IQV) · Health Care

Morgan Stanley rates IQVIA Holdings Inc. (IQV) Equal-Weight with a $200 price target, as of its latest action on Jun 17, 2026. It has published 5 rating actions on IQV since July 2021, including 0 upgrades and 1 downgrade. Across 5 firms with a IQV price target in the last 12 months, the median target is $213. Morgan Stanley's $200 is 6% below that.

Current rating
Equal-Weight
Price target
$200
Median target, all firms
$213
Actions on IQV
5

Morgan Stanley price target on IQV

$290$245$20020222023202420252026
Morgan Stanley price target on IQV, each point a stated target, July 2021 to June 2026.

Every Morgan Stanley rating on IQV

How other firms rate IQV

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSBuy$345Sep 30, 2026
Morgan StanleyEqual-Weight$200Jun 17, 2026
TD CowenBuy$213Mar 9, 2026
BarclaysOverweight$210Mar 6, 2026
RBC Capital MarketsOutperform$221Mar 3, 2026

Questions about Morgan Stanley and IQV

What is Morgan Stanley's price target for IQV?
Morgan Stanley's latest stated price target for IQVIA Holdings Inc. (IQV) is $200, from its action on Jun 17, 2026.
What is Morgan Stanley's rating on IQV?
Morgan Stanley rates IQV Equal-Weight, a neutral rating, as of Jun 17, 2026.
When did Morgan Stanley last change its view on IQV?
On Jun 17, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $200.
How does Morgan Stanley's IQV target compare with other analysts?
Across 5 firms with a IQV price target in the last 12 months, the median target is $213. Morgan Stanley's $200 is 6% below that.

More IQV rating histories

All Morgan Stanley ratingsIQV news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.